Liquidia soars over 40% after agreeing to pay $380.7 million to settle with United Therapeutics and keep YUTREPIA on the market
SentiSense · Published · Updated
Liquidia shares jumped more than 40% after hours after it settled all pending litigation with United Therapeutics. Liquidia will pay a total of $380.7...
Sign in to read the full story. Free accounts include 20 full reads a month.
Powered by SentiSense - Intelligent Market Analysis